Results 81 to 90 of about 1,343 (193)

Neuroprotective effects of the ergoline derivative nicergoline following transient and permanent focal cerebral ischemia in rats [PDF]

, 2015
Chikako Nito, Yasuhiro Nishiyama, Tomonari Saito, Satoshi Suda, Masayuki Ueda, Kazumi Kimura   +5 more
openalex   +1 more source

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study [PDF]

, 1999
Michaela M. Pinter, Oliver Pogarell, Wolfgang H. Oertel   +2 more
openalex   +1 more source

Some Substitution of Derivatives of Ergoline-I with Prolactin-inhibiting Activities

, 1978
J. KREPELKA, M. Semonský
openalex   +1 more source

Psychedelics. [PDF]

Curr Biol, 2022
Kelmendi B, Kaye AP, Pittenger C, Kwan AC.   +3 more
europepmc   +1 more source

AZETIDIN-2-ONE FUSED QUINOLINE ANALOGUES: SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL 2-CHLORO-3-FORMYL QUINOLINE DERIVATIVES [PDF]

, 2016
Objective: The aim of the present invention is to synthesize and find out the biological significance of the series of the designed azetidin-2-one fused 2-chloro-3-formyl quinoline derivatives.
Nayak, Govind, Shrivastava, Birendra, Singhai, Akhlesh Kumar   +2 more
core   +1 more source

Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report. [PDF]

Front Endocrinol (Lausanne), 2022
Lin S, Han C, Lou X, Wu ZB.
europepmc   +1 more source

"Selective" serotonin 5-HT_2A receptor antagonists. [PDF]

Biochem Pharmacol, 2022
Casey AB, Cui M, Booth RG, Canal CE.
europepmc   +1 more source

Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists - LY53857, sergolexole, and LY237733

, 1990
Paul McBride, J. John Mann, Esther A. Nimchinsky, Marlene L. Cohen   +3 more
openalex   +1 more source

Cover Picture: Ergoline‐Derived Inverse Agonists of the Human H3 Receptor for the Treatment of Narcolepsy (ChemMedChem 8/2014) [PDF]

, 2014
Yves P. Auberson, Thomas Troxler, Xuechun Zhang, Charles R. Yang, Markus Fendt, Dominik Feuerbach, Yu‐Chih Liu, Bharat Lagu, Andreas Lerchner, Mark H. Perrone, Lijun Lei, Chao Zhang, Chunxiu Wang, Tielin Wang, Mark G. Bock   +14 more
openalex   +1 more source

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics. [PDF]

Front Psychiatry
Williams ML, Rudin D, Schmid Y, von Salm J.   +3 more
europepmc   +1 more source